PortfoliosLab logoPortfoliosLab logo
IDWR.L vs. QNTM
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

IDWR.L vs. QNTM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in iShares MSCI World UCITS (IDWR.L) and Quantum BioPharma Ltd (QNTM). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, IDWR.L achieves a 9.72% return, which is significantly higher than QNTM's -38.63% return.


IDWR.L

1D
0.09%
1M
4.01%
YTD
9.72%
6M
10.83%
1Y
25.57%
3Y*
20.43%
5Y*
11.53%
10Y*
12.75%

QNTM

1D
-8.20%
1M
-16.42%
YTD
-38.63%
6M
-55.20%
1Y
-69.17%
3Y*
-60.64%
5Y*
-48.49%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

IDWR.L vs. QNTM - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
IDWR.L
iShares MSCI World UCITS
9.72%20.58%18.78%24.08%-18.32%21.58%15.70%26.75%-10.83%
QNTM
Quantum BioPharma Ltd
-38.63%98.37%-93.84%16.67%-22.71%-34.62%-71.27%-87.38%148.84%

Correlation

The correlation between IDWR.L and QNTM is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.11

Correlation (3Y)
Calculated over the trailing 3-year period

0.12

Correlation (5Y)
Calculated over the trailing 5-year period

0.16

Correlation (All Time)
Calculated using the full available price history since Jun 11, 2018

0.16

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

IDWR.L vs. QNTM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IDWR.L
IDWR.L Risk / Return Rank: 6767
Overall Rank
IDWR.L Sharpe Ratio Rank: 6666
Sharpe Ratio Rank
IDWR.L Sortino Ratio Rank: 7272
Sortino Ratio Rank
IDWR.L Omega Ratio Rank: 6666
Omega Ratio Rank
IDWR.L Calmar Ratio Rank: 6363
Calmar Ratio Rank
IDWR.L Martin Ratio Rank: 7171
Martin Ratio Rank

QNTM
QNTM Risk / Return Rank: 2424
Overall Rank
QNTM Sharpe Ratio Rank: 2323
Sharpe Ratio Rank
QNTM Sortino Ratio Rank: 3131
Sortino Ratio Rank
QNTM Omega Ratio Rank: 3131
Omega Ratio Rank
QNTM Calmar Ratio Rank: 1414
Calmar Ratio Rank
QNTM Martin Ratio Rank: 2222
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IDWR.L vs. QNTM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares MSCI World UCITS (IDWR.L) and Quantum BioPharma Ltd (QNTM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


IDWR.LQNTMDifference
Sharpe ratioReturn per unit of total volatility

+2.58

Sortino ratioReturn per unit of downside risk

+3.17

Omega ratioGain probability vs. loss probability

1.39

1.00

+0.39

Calmar ratioReturn relative to maximum drawdown

3.07

-0.74

+3.81

Martin ratioReturn relative to average drawdown

12.98

-0.99

+13.97

IDWR.L vs. QNTM - Sharpe Ratio Comparison

The current IDWR.L Sharpe Ratio is 2.15, which is higher than the QNTM Sharpe Ratio of -0.43. The chart below compares the historical Sharpe Ratios of IDWR.L and QNTM, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


IDWR.LQNTMDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.15

-0.43

+2.58

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.74

-0.36

+1.10

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.80

Sharpe Ratio (All Time)

Calculated using the full available price history

0.46

-0.36

+0.82

Drawdowns

IDWR.L vs. QNTM - Drawdown Comparison

The maximum IDWR.L drawdown since its inception was -56.75%, smaller than the maximum QNTM drawdown of -99.98%. Use the drawdown chart below to compare losses from any high point for IDWR.L and QNTM.


Loading charts...

Drawdown Indicators


IDWR.LQNTMDifference

Max Drawdown

Largest peak-to-trough decline

-56.75%

-99.98%

+43.23%

Max Drawdown (1Y)

Largest decline over 1 year

-8.29%

-94.00%

+85.71%

Max Drawdown (3Y)

Largest decline over 3 years

-17.08%

-97.98%

+80.90%

Max Drawdown (5Y)

Largest decline over 5 years

-26.04%

-98.42%

+72.38%

Max Drawdown (10Y)

Largest decline over 10 years

-34.06%

Current Drawdown

Current decline from peak

-0.46%

-99.95%

+99.49%

Average Drawdown

Average peak-to-trough decline

-9.61%

-92.23%

+82.62%

Ulcer Index

Depth and duration of drawdowns from previous peaks

1.96%

70.16%

-68.20%

Volatility

IDWR.L vs. QNTM - Volatility Comparison

The current volatility for iShares MSCI World UCITS (IDWR.L) is 3.30%, while Quantum BioPharma Ltd (QNTM) has a volatility of 54.90%. This indicates that IDWR.L experiences smaller price fluctuations and is considered to be less risky than QNTM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


IDWR.LQNTMDifference

Volatility (1M)

Calculated over the trailing 1-month period

3.30%

54.90%

-51.60%

Volatility (6M)

Calculated over the trailing 6-month period

9.08%

112.42%

-103.34%

Volatility (1Y)

Calculated over the trailing 1-year period

11.85%

160.03%

-148.18%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

15.60%

134.03%

-118.43%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

15.86%

140.69%

-124.83%

Dividends

IDWR.L vs. QNTM - Dividend Comparison

IDWR.L's dividend yield for the trailing twelve months is around 0.85%, while QNTM has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
IDWR.L
iShares MSCI World UCITS
0.85%0.93%1.08%1.29%1.46%1.05%1.14%1.61%1.87%1.58%1.77%1.83%
QNTM
Quantum BioPharma Ltd
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


IDWR.L and QNTM have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for IDWR.L and QNTM

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer